Spire Wealth Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-43
Closed -$4K 2227
2026
Q1
$4K Buy
+43
New +$3.81K ﹤0.01% 1891
2024
Q3
Sell
-8
Closed -$1.14K 2157
2024
Q2
$1.14K Buy
8
+1
+14% +$115 ﹤0.01% 2101
2024
Q1
$781 Hold
7
﹤0.01% 2242
2023
Q4
$921 Sell
7
-1
-13% -$138 ﹤0.01% 2280
2023
Q3
$1.3K Buy
8
+1
+14% +$176 ﹤0.01% 2209
2023
Q2
$1.28K Sell
7
-3
-30% -$432 ﹤0.01% 2269
2023
Q1
$1.33K Buy
+10
New +$1.18K ﹤0.01% 2347

Other funds holding ACLS

Spire Wealth Management's ACLS Position: Q2 2026 in Review

Spire Wealth Management sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 43 shares — an estimated $4K sold.

Spire Wealth Management first reported a position in ACLS in Q1 2023 and held it in 7 quarters. The position peaked at $4K in Q1 2026. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Spire Wealth Management reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
  • Spire Wealth Management sold 43 Axcelis shares in Q2 2026, an estimated $4K.
  • Spire Wealth Management first reported a position in Axcelis in Q1 2023 and held it in 7 quarters.
  • Spire Wealth Management's Axcelis position peaked at $4K in Q1 2026.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.